vector puc18 h1 rnai Search Results


99
New England Biolabs xbai
Xbai, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vector+puc18+h1+rnai/XbaI/custom%40r0145%4010%2E1074%2Fjbc%2Em910340199
Average 99 stars, based on 1 article reviews
xbai - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

99
New England Biolabs ecori
Ecori, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vector+puc18+h1+rnai/EcoRI/custom%40r0101%4010%2E1074%2Fjbc%2Em910340199
Average 99 stars, based on 1 article reviews
ecori - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

90
Promega puc18 vector
Puc18 Vector, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vector+puc18+h1+rnai/puc18/pmc07782713-281-37-39
Average 90 stars, based on 1 article reviews
puc18 vector - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

95
New England Biolabs bsphi
Bsphi, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vector+puc18+h1+rnai/BspHI/custom%40r0517%4016456032
Average 95 stars, based on 1 article reviews
bsphi - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

99
New England Biolabs t7 rna polymerase
T7 Rna Polymerase, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vector+puc18+h1+rnai/T7+RNA+Polymerase/custom%40m0460%4010%2E1128%2Fjb%2E186%2E23%2E8026-8035%2E2004
Average 99 stars, based on 1 article reviews
t7 rna polymerase - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

90
Promega pgem-t vector
Formation of <t>ARS</t> <t>RNA–protein</t> complex. ( A ) RNA–protein crosslinking by UV. The in vitro synthesized [ 32 P]-labeled ARS RNA (≈3 ng, 3 × 10 5 c.p.m.) was incubated with different cell extract (≈60 µg protein) in the flat cap of a 0.2 ml PCR tube. Following the UV treatment, the samples were treated with RNaseA/RNase T1, analyzed by 10% SDS–PAGE and autoradiographed as described under experimental procedures. Cell extracts from mouse NIH3T3 fibroblasts (lane 2) and C2 myoblasts (lane 3), and human HEK293 (lane 4) and HeLa cells (lane 5) were used for these studies. One sample containing HeLa cell extract (lane 1) was analyzed without UV treatment as a control. Approximately 300 ng of the non-radioactive <t>pGEM-T</t> (lane 6), ARS (lane 7) or poly(A) 50 RNA (lane 8) was used for competition studies. ( B ) Analysis of RNP complex by REMSA. The in vitro synthesized [ 32 P]-labeled ARS RNA (≈1 ng, 1 × 10 5 c.p.m.) was incubated with different cell extracts (20 µg) as indicated above each lane. The unbound RNA was digested with RNaseT1 and subjected to electrophoresis in a 2% agarose as described in the experimental procedures. Lane 1, radioactive ARS RNA incubated without the cell extract; lanes 2–5, radioactive ARS RNA incubated with NIH3T3, C2, HEK293 and HeLa cell extracts, respectively. Lanes 6–8, competition with 100 ng of non-radioactive pGEM-T, ARS, or poly(A) 50 RNA, respectively. Lane 9, cell extract was pre-incubated with the PABP antibody and precleared with protein A-sepharose beads before being used for REMSA. Approximately 20 µg of PABP deficient cell extract was used for REMSA. Lane 10, cell extract was similarly treated with the GFP antibody (BD Biosciences) before being used for REMSA. Lane 11, radiolabeled ARS RNA (≈ 1 ng, 1 × 10 5 c.p.m.) incubated with ≈2 ng of purified 6×His-PABP. ( C ) Analysis of RNP complexes by SDS–PAGE. RNP complex formation was initiated as described above and the samples were irradiated by UV before being resolved in a 2% agarose gel. The RNP bands (as shown in ) were excised from the gel, treated with RNaseA/RNase T1, and analyzed by 10% SDS–PAGE as described in the Materials and Methods. Lane 1, ARS RNA and HeLa extracts treated with UV and analyzed before gel purification. Lane 2, polypeptides from the gel purified slower migrating ARC. Lane 3, polypeptides from the faster migrating minor complex.
Pgem T Vector, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vector+puc18+h1+rnai/pgem+t+easy/pmc01316114-77-31-33
Average 90 stars, based on 1 article reviews
pgem-t vector - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

97
New England Biolabs sali
Formation of <t>ARS</t> <t>RNA–protein</t> complex. ( A ) RNA–protein crosslinking by UV. The in vitro synthesized [ 32 P]-labeled ARS RNA (≈3 ng, 3 × 10 5 c.p.m.) was incubated with different cell extract (≈60 µg protein) in the flat cap of a 0.2 ml PCR tube. Following the UV treatment, the samples were treated with RNaseA/RNase T1, analyzed by 10% SDS–PAGE and autoradiographed as described under experimental procedures. Cell extracts from mouse NIH3T3 fibroblasts (lane 2) and C2 myoblasts (lane 3), and human HEK293 (lane 4) and HeLa cells (lane 5) were used for these studies. One sample containing HeLa cell extract (lane 1) was analyzed without UV treatment as a control. Approximately 300 ng of the non-radioactive <t>pGEM-T</t> (lane 6), ARS (lane 7) or poly(A) 50 RNA (lane 8) was used for competition studies. ( B ) Analysis of RNP complex by REMSA. The in vitro synthesized [ 32 P]-labeled ARS RNA (≈1 ng, 1 × 10 5 c.p.m.) was incubated with different cell extracts (20 µg) as indicated above each lane. The unbound RNA was digested with RNaseT1 and subjected to electrophoresis in a 2% agarose as described in the experimental procedures. Lane 1, radioactive ARS RNA incubated without the cell extract; lanes 2–5, radioactive ARS RNA incubated with NIH3T3, C2, HEK293 and HeLa cell extracts, respectively. Lanes 6–8, competition with 100 ng of non-radioactive pGEM-T, ARS, or poly(A) 50 RNA, respectively. Lane 9, cell extract was pre-incubated with the PABP antibody and precleared with protein A-sepharose beads before being used for REMSA. Approximately 20 µg of PABP deficient cell extract was used for REMSA. Lane 10, cell extract was similarly treated with the GFP antibody (BD Biosciences) before being used for REMSA. Lane 11, radiolabeled ARS RNA (≈ 1 ng, 1 × 10 5 c.p.m.) incubated with ≈2 ng of purified 6×His-PABP. ( C ) Analysis of RNP complexes by SDS–PAGE. RNP complex formation was initiated as described above and the samples were irradiated by UV before being resolved in a 2% agarose gel. The RNP bands (as shown in ) were excised from the gel, treated with RNaseA/RNase T1, and analyzed by 10% SDS–PAGE as described in the Materials and Methods. Lane 1, ARS RNA and HeLa extracts treated with UV and analyzed before gel purification. Lane 2, polypeptides from the gel purified slower migrating ARC. Lane 3, polypeptides from the faster migrating minor complex.
Sali, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vector+puc18+h1+rnai/SalI/custom%40r0138%4010%2E1128%2Fjb%2E186%2E23%2E8026-8035%2E2004
Average 97 stars, based on 1 article reviews
sali - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier

90
Promega t 7 rna polymerase
Formation of <t>ARS</t> <t>RNA–protein</t> complex. ( A ) RNA–protein crosslinking by UV. The in vitro synthesized [ 32 P]-labeled ARS RNA (≈3 ng, 3 × 10 5 c.p.m.) was incubated with different cell extract (≈60 µg protein) in the flat cap of a 0.2 ml PCR tube. Following the UV treatment, the samples were treated with RNaseA/RNase T1, analyzed by 10% SDS–PAGE and autoradiographed as described under experimental procedures. Cell extracts from mouse NIH3T3 fibroblasts (lane 2) and C2 myoblasts (lane 3), and human HEK293 (lane 4) and HeLa cells (lane 5) were used for these studies. One sample containing HeLa cell extract (lane 1) was analyzed without UV treatment as a control. Approximately 300 ng of the non-radioactive <t>pGEM-T</t> (lane 6), ARS (lane 7) or poly(A) 50 RNA (lane 8) was used for competition studies. ( B ) Analysis of RNP complex by REMSA. The in vitro synthesized [ 32 P]-labeled ARS RNA (≈1 ng, 1 × 10 5 c.p.m.) was incubated with different cell extracts (20 µg) as indicated above each lane. The unbound RNA was digested with RNaseT1 and subjected to electrophoresis in a 2% agarose as described in the experimental procedures. Lane 1, radioactive ARS RNA incubated without the cell extract; lanes 2–5, radioactive ARS RNA incubated with NIH3T3, C2, HEK293 and HeLa cell extracts, respectively. Lanes 6–8, competition with 100 ng of non-radioactive pGEM-T, ARS, or poly(A) 50 RNA, respectively. Lane 9, cell extract was pre-incubated with the PABP antibody and precleared with protein A-sepharose beads before being used for REMSA. Approximately 20 µg of PABP deficient cell extract was used for REMSA. Lane 10, cell extract was similarly treated with the GFP antibody (BD Biosciences) before being used for REMSA. Lane 11, radiolabeled ARS RNA (≈ 1 ng, 1 × 10 5 c.p.m.) incubated with ≈2 ng of purified 6×His-PABP. ( C ) Analysis of RNP complexes by SDS–PAGE. RNP complex formation was initiated as described above and the samples were irradiated by UV before being resolved in a 2% agarose gel. The RNP bands (as shown in ) were excised from the gel, treated with RNaseA/RNase T1, and analyzed by 10% SDS–PAGE as described in the Materials and Methods. Lane 1, ARS RNA and HeLa extracts treated with UV and analyzed before gel purification. Lane 2, polypeptides from the gel purified slower migrating ARC. Lane 3, polypeptides from the faster migrating minor complex.
T 7 Rna Polymerase, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vector+puc18+h1+rnai/t7+rna+polymerase/pmc01316114-77-21-33
Average 90 stars, based on 1 article reviews
t 7 rna polymerase - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

99
New England Biolabs bbsi
Formation of <t>ARS</t> <t>RNA–protein</t> complex. ( A ) RNA–protein crosslinking by UV. The in vitro synthesized [ 32 P]-labeled ARS RNA (≈3 ng, 3 × 10 5 c.p.m.) was incubated with different cell extract (≈60 µg protein) in the flat cap of a 0.2 ml PCR tube. Following the UV treatment, the samples were treated with RNaseA/RNase T1, analyzed by 10% SDS–PAGE and autoradiographed as described under experimental procedures. Cell extracts from mouse NIH3T3 fibroblasts (lane 2) and C2 myoblasts (lane 3), and human HEK293 (lane 4) and HeLa cells (lane 5) were used for these studies. One sample containing HeLa cell extract (lane 1) was analyzed without UV treatment as a control. Approximately 300 ng of the non-radioactive <t>pGEM-T</t> (lane 6), ARS (lane 7) or poly(A) 50 RNA (lane 8) was used for competition studies. ( B ) Analysis of RNP complex by REMSA. The in vitro synthesized [ 32 P]-labeled ARS RNA (≈1 ng, 1 × 10 5 c.p.m.) was incubated with different cell extracts (20 µg) as indicated above each lane. The unbound RNA was digested with RNaseT1 and subjected to electrophoresis in a 2% agarose as described in the experimental procedures. Lane 1, radioactive ARS RNA incubated without the cell extract; lanes 2–5, radioactive ARS RNA incubated with NIH3T3, C2, HEK293 and HeLa cell extracts, respectively. Lanes 6–8, competition with 100 ng of non-radioactive pGEM-T, ARS, or poly(A) 50 RNA, respectively. Lane 9, cell extract was pre-incubated with the PABP antibody and precleared with protein A-sepharose beads before being used for REMSA. Approximately 20 µg of PABP deficient cell extract was used for REMSA. Lane 10, cell extract was similarly treated with the GFP antibody (BD Biosciences) before being used for REMSA. Lane 11, radiolabeled ARS RNA (≈ 1 ng, 1 × 10 5 c.p.m.) incubated with ≈2 ng of purified 6×His-PABP. ( C ) Analysis of RNP complexes by SDS–PAGE. RNP complex formation was initiated as described above and the samples were irradiated by UV before being resolved in a 2% agarose gel. The RNP bands (as shown in ) were excised from the gel, treated with RNaseA/RNase T1, and analyzed by 10% SDS–PAGE as described in the Materials and Methods. Lane 1, ARS RNA and HeLa extracts treated with UV and analyzed before gel purification. Lane 2, polypeptides from the gel purified slower migrating ARC. Lane 3, polypeptides from the faster migrating minor complex.
Bbsi, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vector+puc18+h1+rnai/BbsI/custom%40r0539%4036045135
Average 99 stars, based on 1 article reviews
bbsi - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

99
New England Biolabs neb 5-alpha competent e. coli
Formation of <t>ARS</t> <t>RNA–protein</t> complex. ( A ) RNA–protein crosslinking by UV. The in vitro synthesized [ 32 P]-labeled ARS RNA (≈3 ng, 3 × 10 5 c.p.m.) was incubated with different cell extract (≈60 µg protein) in the flat cap of a 0.2 ml PCR tube. Following the UV treatment, the samples were treated with RNaseA/RNase T1, analyzed by 10% SDS–PAGE and autoradiographed as described under experimental procedures. Cell extracts from mouse NIH3T3 fibroblasts (lane 2) and C2 myoblasts (lane 3), and human HEK293 (lane 4) and HeLa cells (lane 5) were used for these studies. One sample containing HeLa cell extract (lane 1) was analyzed without UV treatment as a control. Approximately 300 ng of the non-radioactive <t>pGEM-T</t> (lane 6), ARS (lane 7) or poly(A) 50 RNA (lane 8) was used for competition studies. ( B ) Analysis of RNP complex by REMSA. The in vitro synthesized [ 32 P]-labeled ARS RNA (≈1 ng, 1 × 10 5 c.p.m.) was incubated with different cell extracts (20 µg) as indicated above each lane. The unbound RNA was digested with RNaseT1 and subjected to electrophoresis in a 2% agarose as described in the experimental procedures. Lane 1, radioactive ARS RNA incubated without the cell extract; lanes 2–5, radioactive ARS RNA incubated with NIH3T3, C2, HEK293 and HeLa cell extracts, respectively. Lanes 6–8, competition with 100 ng of non-radioactive pGEM-T, ARS, or poly(A) 50 RNA, respectively. Lane 9, cell extract was pre-incubated with the PABP antibody and precleared with protein A-sepharose beads before being used for REMSA. Approximately 20 µg of PABP deficient cell extract was used for REMSA. Lane 10, cell extract was similarly treated with the GFP antibody (BD Biosciences) before being used for REMSA. Lane 11, radiolabeled ARS RNA (≈ 1 ng, 1 × 10 5 c.p.m.) incubated with ≈2 ng of purified 6×His-PABP. ( C ) Analysis of RNP complexes by SDS–PAGE. RNP complex formation was initiated as described above and the samples were irradiated by UV before being resolved in a 2% agarose gel. The RNP bands (as shown in ) were excised from the gel, treated with RNaseA/RNase T1, and analyzed by 10% SDS–PAGE as described in the Materials and Methods. Lane 1, ARS RNA and HeLa extracts treated with UV and analyzed before gel purification. Lane 2, polypeptides from the gel purified slower migrating ARC. Lane 3, polypeptides from the faster migrating minor complex.
Neb 5 Alpha Competent E. Coli, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vector+puc18+h1+rnai/NEB+5-alpha+Competent+E%2E+coli/custom%40c2987%4036045135
Average 99 stars, based on 1 article reviews
neb 5-alpha competent e. coli - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

Image Search Results


Formation of ARS RNA–protein complex. ( A ) RNA–protein crosslinking by UV. The in vitro synthesized [ 32 P]-labeled ARS RNA (≈3 ng, 3 × 10 5 c.p.m.) was incubated with different cell extract (≈60 µg protein) in the flat cap of a 0.2 ml PCR tube. Following the UV treatment, the samples were treated with RNaseA/RNase T1, analyzed by 10% SDS–PAGE and autoradiographed as described under experimental procedures. Cell extracts from mouse NIH3T3 fibroblasts (lane 2) and C2 myoblasts (lane 3), and human HEK293 (lane 4) and HeLa cells (lane 5) were used for these studies. One sample containing HeLa cell extract (lane 1) was analyzed without UV treatment as a control. Approximately 300 ng of the non-radioactive pGEM-T (lane 6), ARS (lane 7) or poly(A) 50 RNA (lane 8) was used for competition studies. ( B ) Analysis of RNP complex by REMSA. The in vitro synthesized [ 32 P]-labeled ARS RNA (≈1 ng, 1 × 10 5 c.p.m.) was incubated with different cell extracts (20 µg) as indicated above each lane. The unbound RNA was digested with RNaseT1 and subjected to electrophoresis in a 2% agarose as described in the experimental procedures. Lane 1, radioactive ARS RNA incubated without the cell extract; lanes 2–5, radioactive ARS RNA incubated with NIH3T3, C2, HEK293 and HeLa cell extracts, respectively. Lanes 6–8, competition with 100 ng of non-radioactive pGEM-T, ARS, or poly(A) 50 RNA, respectively. Lane 9, cell extract was pre-incubated with the PABP antibody and precleared with protein A-sepharose beads before being used for REMSA. Approximately 20 µg of PABP deficient cell extract was used for REMSA. Lane 10, cell extract was similarly treated with the GFP antibody (BD Biosciences) before being used for REMSA. Lane 11, radiolabeled ARS RNA (≈ 1 ng, 1 × 10 5 c.p.m.) incubated with ≈2 ng of purified 6×His-PABP. ( C ) Analysis of RNP complexes by SDS–PAGE. RNP complex formation was initiated as described above and the samples were irradiated by UV before being resolved in a 2% agarose gel. The RNP bands (as shown in ) were excised from the gel, treated with RNaseA/RNase T1, and analyzed by 10% SDS–PAGE as described in the Materials and Methods. Lane 1, ARS RNA and HeLa extracts treated with UV and analyzed before gel purification. Lane 2, polypeptides from the gel purified slower migrating ARC. Lane 3, polypeptides from the faster migrating minor complex.

Journal: Nucleic Acids Research

Article Title: The autoregulatory translational control element of poly(A)-binding protein mRNA forms a heteromeric ribonucleoprotein complex

doi: 10.1093/nar/gki1014

Figure Lengend Snippet: Formation of ARS RNA–protein complex. ( A ) RNA–protein crosslinking by UV. The in vitro synthesized [ 32 P]-labeled ARS RNA (≈3 ng, 3 × 10 5 c.p.m.) was incubated with different cell extract (≈60 µg protein) in the flat cap of a 0.2 ml PCR tube. Following the UV treatment, the samples were treated with RNaseA/RNase T1, analyzed by 10% SDS–PAGE and autoradiographed as described under experimental procedures. Cell extracts from mouse NIH3T3 fibroblasts (lane 2) and C2 myoblasts (lane 3), and human HEK293 (lane 4) and HeLa cells (lane 5) were used for these studies. One sample containing HeLa cell extract (lane 1) was analyzed without UV treatment as a control. Approximately 300 ng of the non-radioactive pGEM-T (lane 6), ARS (lane 7) or poly(A) 50 RNA (lane 8) was used for competition studies. ( B ) Analysis of RNP complex by REMSA. The in vitro synthesized [ 32 P]-labeled ARS RNA (≈1 ng, 1 × 10 5 c.p.m.) was incubated with different cell extracts (20 µg) as indicated above each lane. The unbound RNA was digested with RNaseT1 and subjected to electrophoresis in a 2% agarose as described in the experimental procedures. Lane 1, radioactive ARS RNA incubated without the cell extract; lanes 2–5, radioactive ARS RNA incubated with NIH3T3, C2, HEK293 and HeLa cell extracts, respectively. Lanes 6–8, competition with 100 ng of non-radioactive pGEM-T, ARS, or poly(A) 50 RNA, respectively. Lane 9, cell extract was pre-incubated with the PABP antibody and precleared with protein A-sepharose beads before being used for REMSA. Approximately 20 µg of PABP deficient cell extract was used for REMSA. Lane 10, cell extract was similarly treated with the GFP antibody (BD Biosciences) before being used for REMSA. Lane 11, radiolabeled ARS RNA (≈ 1 ng, 1 × 10 5 c.p.m.) incubated with ≈2 ng of purified 6×His-PABP. ( C ) Analysis of RNP complexes by SDS–PAGE. RNP complex formation was initiated as described above and the samples were irradiated by UV before being resolved in a 2% agarose gel. The RNP bands (as shown in ) were excised from the gel, treated with RNaseA/RNase T1, and analyzed by 10% SDS–PAGE as described in the Materials and Methods. Lane 1, ARS RNA and HeLa extracts treated with UV and analyzed before gel purification. Lane 2, polypeptides from the gel purified slower migrating ARC. Lane 3, polypeptides from the faster migrating minor complex.

Article Snippet: The pUC18 or pEGFP-N3 plasmids containing either oligo(A) of different length, wild-type or mutant ARS region under the control of the T 7 RNA polymerase sequence were linearized with BamHI, and pGEM-T vector (Promega) was linearized with SalI restriction enzyme for in vitro run-off transcription.

Techniques: In Vitro, Synthesized, Labeling, Incubation, SDS Page, Electrophoresis, Purification, Irradiation, Agarose Gel Electrophoresis, Gel Purification

Affinity chromatography of ARS RNA-binding proteins. In vitro synthesized ARS RNA was covalently linked to agarose beads and incubated with HeLa cell extract. The bound polypeptides were eluted, resolved on 10% SDS–PAGE and visualized by silver staining. Lane 1, pGEM-T and lane 2, ARS RNA bound protein fractions. The polypeptides specific for the ARS RNA affinity chromatography are shown by arrows. The polypeptides with bold arrows were seen in the UV crosslinking experiments.

Journal: Nucleic Acids Research

Article Title: The autoregulatory translational control element of poly(A)-binding protein mRNA forms a heteromeric ribonucleoprotein complex

doi: 10.1093/nar/gki1014

Figure Lengend Snippet: Affinity chromatography of ARS RNA-binding proteins. In vitro synthesized ARS RNA was covalently linked to agarose beads and incubated with HeLa cell extract. The bound polypeptides were eluted, resolved on 10% SDS–PAGE and visualized by silver staining. Lane 1, pGEM-T and lane 2, ARS RNA bound protein fractions. The polypeptides specific for the ARS RNA affinity chromatography are shown by arrows. The polypeptides with bold arrows were seen in the UV crosslinking experiments.

Article Snippet: The pUC18 or pEGFP-N3 plasmids containing either oligo(A) of different length, wild-type or mutant ARS region under the control of the T 7 RNA polymerase sequence were linearized with BamHI, and pGEM-T vector (Promega) was linearized with SalI restriction enzyme for in vitro run-off transcription.

Techniques: Affinity Chromatography, RNA Binding Assay, In Vitro, Synthesized, Incubation, SDS Page, Silver Staining